TransCode Therapeutics - SEC Filing
Por um escritor misterioso
Descrição
tm2324931-9_424b4 - none - 6.2187646s
EDGAR Filing Documents for 0001104659-21-029169
RNAZ - TransCode Therapeutics Announces Pricing of $8 Million
SurgePays Announces Closing of Upsize
Endpoints News — Prometheus shares skyrocket on PhII data; FDA
EDGAR Filing Documents for 0001104659-21-029169
Capital Ventures International Increases Ownership in Marathon
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
de
por adulto (o preço varia de acordo com o tamanho do grupo)
